Literature DB >> 27154354

TRAF3 as a powerful and multitalented regulator of lymphocyte functions.

Gail A Bishop1,2,3.   

Abstract

This review summarizes the current state of knowledge regarding the roles of the signaling adapter protein tumor necrosis factor receptor (TNFR)-associated factor 3 in regulating the functions of B and T lymphocytes. In B lymphocytes, TNFR-associated factor 3 inhibits signaling by TNFR superfamily receptors, Toll-like receptors, and interleukin-6R. In contrast, signaling to B cells by the virally encoded oncogenic protein latent membrane protein 1 is promoted by TNFR-associated factor 3. An important B cell-specific role for TNFR-associated factor 3 is the inhibition of homeostatic survival, directly relevant to the common occurrence of TNFR-associated factor 3 mutations in human B cell malignancies. TNFR-associated factor 3 was recently found to be a resident nuclear protein in B cells, where it interacts with and inhibits gene expression mediated by the cAMP response element-binding protein transcription complex, including expression of the prosurvival protein myeloid leukemia cell differentiation protein 1. In T lymphocytes, TNFR-associated factor 3 is required for normal signaling by the T cell antigen receptor, while inhibiting signaling by the interleukin-2 receptor. Cytoplasmic TNFR -associated factor 3 restrains nuclear factor-κB2 activation in both T and B cells. Clinical implications and future directions for the study of this context-dependent signaling regulator are discussed. © Society for Leukocyte Biology.

Entities:  

Keywords:  B cell; T cell; signal transduction

Mesh:

Substances:

Year:  2016        PMID: 27154354      PMCID: PMC6608063          DOI: 10.1189/jlb.2MR0216-063R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  98 in total

1.  Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).

Authors:  K D Brown; B S Hostager; G A Bishop
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

2.  Caspase-mediated cleavage of TRAF3 in FasL-stimulated Jurkat-T cells.

Authors:  Z H Lee; S E Lee; K Kwack; W Yeo; T H Lee; S S Bae; P G Suh; H H Kim
Journal:  J Leukoc Biol       Date:  2001-03       Impact factor: 4.962

3.  Complete structural characterisation of the mammalian and Drosophila TRAF genes: implications for TRAF evolution and the role of RING finger splice variants.

Authors:  A Grech; R Quinn; D Srinivasan; X Badoux; R Brink
Journal:  Mol Immunol       Date:  2000 Aug-Sep       Impact factor: 4.407

4.  Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling.

Authors:  B S Hostager; I M Catlett; G A Bishop
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

5.  TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.

Authors:  M A Lomaga; W C Yeh; I Sarosi; G S Duncan; C Furlonger; A Ho; S Morony; C Capparelli; G Van; S Kaufman; A van der Heiden; A Itie; A Wakeham; W Khoo; T Sasaki; Z Cao; J M Penninger; C J Paige; D L Lacey; C R Dunstan; W J Boyle; D V Goeddel; T W Mak
Journal:  Genes Dev       Date:  1999-04-15       Impact factor: 11.361

6.  Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation.

Authors:  B S Hostager; G A Bishop
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

7.  Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation.

Authors:  H Nakano; S Sakon; H Koseki; T Takemori; K Tada; M Matsumoto; E Munechika; T Sakai; T Shirasawa; H Akiba; T Kobata; S M Santee; C F Ware; P D Rennert; M Taniguchi; H Yagita; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

8.  Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain.

Authors:  V Baud; Z G Liu; B Bennett; N Suzuki; Y Xia; M Karin
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

9.  The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes.

Authors:  L K Busch; G A Bishop
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

10.  Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.

Authors:  J Uchida; T Yasui; Y Takaoka-Shichijo; M Muraoka; W Kulwichit; N Raab-Traub; H Kikutani
Journal:  Science       Date:  1999-10-08       Impact factor: 47.728

View more
  11 in total

Review 1.  TRAF family molecules in T cells: Multiple receptors and functions.

Authors:  Tina Arkee; Gail A Bishop
Journal:  J Leukoc Biol       Date:  2019-11-21       Impact factor: 4.962

2.  The Chx10-Traf3 Knockout Mouse as a Viable Model to Study Neuronal Immune Regulation.

Authors:  Jami M Gurley; Grzegorz B Gmyrek; Elizabeth A Hargis; Gail A Bishop; Daniel J J Carr; Michael H Elliott
Journal:  Cells       Date:  2021-08-12       Impact factor: 7.666

3.  TRAF2 Deficiency in B Cells Impairs CD40-Induced Isotype Switching That Can Be Rescued by Restoring NF-κB1 Activation.

Authors:  Rachel A Woolaver; Xiaoguang Wang; Yonatan Dollin; Ping Xie; Jing H Wang; Zhangguo Chen
Journal:  J Immunol       Date:  2018-10-19       Impact factor: 5.422

4.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20

Review 5.  TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation.

Authors:  Gail A Bishop; Laura L Stunz; Bruce S Hostager
Journal:  Front Immunol       Date:  2018-09-24       Impact factor: 7.561

Review 6.  Regulation of Interleukin-6 Receptor Signaling by TNF Receptor-Associated Factor 2 and 5 During Differentiation of Inflammatory CD4+ T Cells.

Authors:  Hiroyuki Nagashima; Naoto Ishii; Takanori So
Journal:  Front Immunol       Date:  2018-08-30       Impact factor: 7.561

7.  TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis.

Authors:  Jinbo Li; Akram Ayoub; Yan Xiu; Xiaoxiang Yin; James O Sanders; Addisu Mesfin; Lianping Xing; Zhenqiang Yao; Brendan F Boyce
Journal:  Nat Commun       Date:  2019-06-26       Impact factor: 14.919

8.  Difference of genomic copy numbers alterations between hairy cell leukemia-variant and classical hairy cell leukemia: a pilot retrospective study in Chinese.

Authors:  Rui Zhang; Yongli Wu; Xianfu Wang; Xianglan Lu; Yan Li; Shibo Li; Xiaojing Yan
Journal:  Int J Med Sci       Date:  2020-01-18       Impact factor: 3.738

9.  Neuroretinal-Derived Caveolin-1 Promotes Endotoxin-Induced Inflammation in the Murine Retina.

Authors:  Jami M Gurley; Grzegorz B Gmyrek; Mark E McClellan; Elizabeth A Hargis; Stefanie M Hauck; Mikhail G Dozmorov; Jonathan D Wren; Daniel J J Carr; Michael H Elliott
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-10-01       Impact factor: 4.799

10.  TRAF3 in T Cells Restrains Negative Regulators of LAT to Promote TCR/CD28 Signaling.

Authors:  Tina Arkee; Bruce S Hostager; Jon C D Houtman; Gail A Bishop
Journal:  J Immunol       Date:  2021-06-18       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.